Gottron Sign with Ulceration Is Not a Poor Prognostic Factor in Patients with Dermatomyositis and Interstitial Lung Disease

被引：6
|
作者：
Nagashima, Takao [1 ]
Iwamoto, Masahiro [1 ]
Minota, Seiji [1 ]
机构：
[1] Jichi Med Univ, Dept Med, Div Rheumatol & Clin Immunol, Yakushiji 3311-1, Shimotsuke, Tochigi, Japan
来源：
JOURNAL OF RHEUMATOLOGY | 2017年 / 44卷 / 07期
关键词：
GENE; 5; POLYMYOSITIS; TACROLIMUS; EFFICACY;
D O I：
10.3899/jrheum.170068
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1099 / U179
页数：2
相关论文
共 50 条
  • [31] Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study
    Ji Su-yun
    Zeng Fan-qin
    Guo Qing
    Tan Guo-zhen
    Tang Hong-feng
    Luo Yi-jin
    Tang Zeng-qi
    Han Yan-fang
    CHINESE MEDICAL JOURNAL, 2010, 123 (05) : 517 - 522
  • [32] The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
    Sugiyama, Yumiko
    Yoshimi, Ryusuke
    Tamura, Maasa
    Takeno, Mitsuhiro
    Kunishita, Yosuke
    Kishimoto, Daiga
    Yoshioka, Yuji
    Kobayashi, Kouji
    Takase-Minegishi, Kaoru
    Watanabe, Toshiyuki
    Hamada, Naoki
    Nagai, Hideto
    Tsuchida, Naomi
    Soejima, Yutaro
    Nakano, Hiroto
    Kamiyama, Reikou
    Uehara, Takeaki
    Kirino, Yohei
    Sekiguchi, Akiko
    Ihata, Atsushi
    Ohno, Shigeru
    Nagaoka, Shouhei
    Nakajima, Hideaki
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [33] Is the Presence of Esophageal Dilation a Poor Prognostic Factor in Dilated Interstitial Lung Disease Associated with Systemic Sclerosis?
    Narvaez, Javier
    Heredia, Sergi
    Borrell Panos, Helena
    Armengol, Eulalia
    De Lama, Eugenia
    Antonio Narvaez, Jose
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [34] Anti-MDA5-Antibody Is Not Prognostic Markerin the Chronic Phase of Interstitial Lung Disease in Patients with Dermatomyositis
    Sakamoto, S.
    Okamoto, M.
    Kaieda, S.
    Nakamura, M.
    Nouno, T.
    Koga, T.
    Tominaga, M.
    Kawayama, T.
    Kuwana, M.
    Ida, H.
    Hoshino, T.
    Fujimoto, K.
    Nagata, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [35] When and how should the patients with dermatomyositis be assessed for interstitial lung disease?
    GUO Lishao and ZHANG Jianzhong Chinese Medical Journal Chinese Medical Association Beijing China Department of Dermatology Peking University Peoples HospitalBeijing China
    中华医学杂志（英文版）, 2010, (05) : 515 - 516
  • [36] When and how should the patients with dermatomyositis be assessed for interstitial lung disease?
    Guo Li-shao
    Zhang Jian-zhong
    CHINESE MEDICAL JOURNAL, 2010, 123 (05) : 515 - 516
  • [37] Interstitial lung disease in polymyositis and dermatomyositis.
    Schnabel A.
    Hellmich B.
    Gross W.L.
    Current Rheumatology Reports, 2005, 7 (2) : 99 - 105
  • [38] Interstitial lung disease in polymyositis and dermatomyositis.
    Marie, I
    Dominique, S
    Rémy-Jardin, M
    Hatron, PY
    Hachulla, E
    REVUE DE MEDECINE INTERNE, 2001, 22 (11): : 1083 - 1096
  • [39] INTERSTITIAL LUNG-DISEASE IN POLYMYOSITIS AND DERMATOMYOSITIS
    SONGCHAROEN, S
    RAJU, SF
    PENNEBAKER, JB
    JOURNAL OF RHEUMATOLOGY, 1980, 7 (03) : 353 - 360
  • [40] Mycophenolate Mofetil for Interstitial Lung Disease in Dermatomyositis
    Morganroth, Pamela A.
    Kreider, Mary Elizabeth
    Werth, Victoria P.
    ARTHRITIS CARE & RESEARCH, 2010, 62 (10) : 1496 - 1501
12345